Highlight
Summary
About the Role
About You
- Ph.D. in analytical chemistry or relevant field with 10+ years of relevant hands-on pharmaceutical/biotech industry experience.
- Extensive hands-on experience with analytical technologies including UHPLC, GC, LC-MS, and others.
- Experience in late-stage pharmaceutical drug development and authoring an NDA for a small molecule commercial product.
- Working understanding of ICH and regulatory guidances.
Benefits
- Competitive salary range of $150k–$220k depending on location and experience.
- Flexible work arrangements including onsite, hybrid, or remote options.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (3) ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens, being developed for multiple myeloma. Beyond these three product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.